News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
CAGNONI PABLO J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2023 |
4
| CAGNONI PABLO J (President, R&D) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 179,613 shares
@ $0 |
|
| 02/01/2023 |
4
| CAGNONI PABLO J (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 8,448 shares
@ $0.25, valued at
$2.1k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| CAGNONI PABLO J (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 6,730 shares
@ $6.573, valued at
$44.2k
Exercised 21,250 restricted stock units
@ $0
Granted 365,000 options to buy
@ $6.75, valued at
$2.5M
Granted 100,000 restricted stock units
@ $0 |
|
| 06/07/2021 |
4
| CAGNONI PABLO J (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 17,000 options to buy
@ $8.15, valued at
$138.6k
|
|
| 02/02/2021 |
4
| CAGNONI PABLO J (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 375,000 options to buy
@ $11.97, valued at
$4.5M
Granted 85,000 restricted stock units
@ $0 |
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2020 |
4
| CAGNONI PABLO J (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Bought 21,000 shares
@ $4.6997, valued at
$98.7k
|
|
| 02/03/2020 |
4
| CAGNONI PABLO J (CEO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $7.8, valued at
$3.9M
|
|
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2019 |
4
| CAGNONI PABLO J (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 15,000 options to buy
@ $43.52, valued at
$652.8k
|
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2018 |
4
| CAGNONI PABLO J (CEO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 164,400 options to buy
@ $16.43, valued at
$2.7M
Granted 193,400 options to buy
@ $16.43, valued at
$3.2M
|
|
| 07/05/2018 |
4
| CAGNONI PABLO J (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 5,816 shares
@ $62, valued at
$360.6k
Sold 1,684 shares
@ $62, valued at
$104.4k
Exercised 5,816 options to buy
@ $5.59, valued at
$32.5k
Exercised 1,684 options to buy
@ $5.59, valued at
$9.4k
|
|
| 06/15/2018 |
4
| CAGNONI PABLO J (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 15,000 options to buy
@ $59.31, valued at
$889.7k
|
|
| 10/20/2016 |
4
| CAGNONI PABLO J (Director) has filed a Form 4 on CRISPR Therapeutics AG |
| 10/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/13/2013 |
4
| CAGNONI PABLO J (EVP, Global R&D and Tech Ops) has filed a Form 4 on ONYX PHARMACEUTICALS INC|
Txns:
| Granted 16,257 shares
@ $0
Granted 34,030 options to buy
@ $87.83, valued at
$3M
|
|
| 10/02/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2009 |
4
| CAGNONI PABLO J (Sr. VP, Chief Medical Officer) has filed a Form 4 on ALLOS THERAPEUTICS INC |
| 02/25/2009 |
4
| CAGNONI PABLO J (Sr. VP, Chief Medical Officer) has filed a Form 4 on ALLOS THERAPEUTICS INC |
|
|